a
a
Weather:
No weather information available
HomeHealthPLPC-DB™: Non-Cellular Oncology Immunotherapy with STIP-NAM Traceability, Entering a Global Acquisition Window.

PLPC-DB™: Non-Cellular Oncology Immunotherapy with STIP-NAM Traceability, Entering a Global Acquisition Window.

ORLANDO, Fla., Sept. 3, 2025 /PRNewswire/ — OGRD Alliance announces PLPC-DB, a non-cellular oncology immunotherapy platform designed to overcome the barriers of cost, scalability, and infrastructure in cancer innovation. Unlike cell- or gene-based therapies, PLPC-DB is a lyophilized…

No comments

Sorry, the comment form is closed at this time.

Translate »